课题基金 / 基金详情

AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY

AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
氨基胍在患有明显糖尿病肾病的糖尿病患者中的应用
批准号：
5221071
负责人：
G APPEL
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5221071
关键词：
adrenal disorder aminoguanidine clinical research clinical trials diabetes mellitus therapy diabetic nephropathy diabetic retinopathy human subject human therapy evaluation pathologic process placebos

项目摘要

项目成果

G APPEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A placebo controlled study of Aminoguanidine in patients with diabetic Nephropathy to see whether the agent is effective in slowing the progression of renal disease in diabetics. Secondary endpoints will include the study of the effect of Aminoguanidine on diabetic retinopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
AMINOGUANIDINE IN DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
海外基金